Background: Patients with acute coronary syndrome (ACS) are at high risk of contrast-induced nephropathy (CIN), which is associated with prolonged hospitalization, higher morbidity and mortality after angiographic procedures. The occurrence of CIN is regarded as a transient and reversible condition. However, the persistence of CIN until hospital discharge in patients with ACS has not been thoroughly analyzed.
View Article and Find Full Text PDFBackground: It is unclear if patients with intermediate coronary artery lesions (40-70% of diameter reduction) benefit from percutaneous coronary intervention (PCI) as compared with pharmacological treatment.
Aim: To investigate whether PCI of intermediate coronary artery lesions may improve the outcome in this group of patients.
Methods: We performed a retrospective analysis of data of 232 symptomatic patients with intermediate coronary lesions.